Xilio Therapeutics, Inc. Employee Directory
Biotechnology ResearchMassachusetts, United States51-200 Employees
Xilio Therapeutics, Inc. is a clinical-stage biotechnology company based in Waltham, Massachusetts, focusing on cancer treatment. Its work centers on therapies that activate within the tumor environment, aiming to produce strong anti-tumor effects while reducing systemic toxicity. The company describes its approach as masking to control activity and selectively unleashing therapeutic action where it is needed, with a pipeline that includes engineered antibodies, cytokines, and chemokines as potential cancer treatments. Xilio targets oncologic indications through immuno-oncology therapies designed to limit adverse experiences associated with broadly active agents. Its ongoing activities include presenting preclinical data and advancing programs in collaboration with the broader biopharma ecosystem, including participation in scientific forums and board-level governance changes. The organization operates in the biotechnology research sector and is positioned as a clinical-stage player developing tumor-focused therapies in a competitive field.
1-888-653-2347 
support@leadiq.com 
